Undeclared muscle relaxants and anti-inflammatory drugs could interact with a patient’s care.
Undeclared muscle relaxants and anti-inflammatory drugs could interact with a patient’s care.
VX-548 delivered significant improvements in pain with few adverse events.
A new study found that VR sessions averaged a 40% reduction in pain and decreased opioid use.
A WCRI study found that in some states 17% of workers receive topical analgesics.
With opioid utilization decreasing, what concerns do other pain therapies pose?
FDA investigates claims that NSAID use could aggravate COVID-19 symptoms.
In a special partner post with WorkCompWire, Healthesystems discusses developments in pain management, specialty drugs, and more.
